PMID- 29225103 OWN - NLM STAT- MEDLINE DCOM- 20190102 LR - 20190102 IS - 2174-2030 (Electronic) IS - 0870-2551 (Linking) VI - 36 IP - 12 DP - 2017 Dec TI - What happens to non-responders in cardiac resynchronization therapy? PG - 885-892 LID - S0870-2551(16)30370-5 [pii] LID - 10.1016/j.repc.2017.02.017 [doi] AB - INTRODUCTION AND OBJECTIVES: Left ventricular reverse remodeling (LVRR) is strongly related to the long-term prognosis of patients undergoing cardiac resynchronization therapy (CRT). The aim of this study was to assess the long-term clinical outcome of patients without LVRR at six months after CRT implantation and to determine the prognostic impact of clinical response in this population. METHODS: We analyzed 178 consecutive patients who underwent successful CRT device implantation (age 64+/-11 years; 69% male; 89% in New York Heart Association [NYHA] functional class III; 35% with ischemic cardiomyopathy). Clinical status and echocardiographic parameters were determined before and six months after CRT implantation. We identified those without criteria for LVRR (>/=10% increase in left ventricular ejection fraction with >/=15% reduction in left ventricular end-systolic diameter compared to baseline). Clinical responders were defined by a sustained improvement of at least one NYHA functional class. RESULTS: At six-month assessment after CRT, 109 (61%) patients showed LVRR. During a mean follow-up of 56+/-21 months, 47 (26%) patients died, with higher mortality in the group without LVRR (36% vs. 20%, p=0.023). Clinical response was greater in patients with LVRR (88% vs. 55%, p<0.001). In patients without LVRR, clinical response to CRT was the strongest independent predictor of survival (hazard ratio: 0.120; 95% confidence interval: 0.039-0.366; p<0.001). CONCLUSION: Although patients without LVRR six months after CRT implantation had a worse prognosis, with higher all-cause mortality, clinical response can be an independent predictor of survival in this population. CI - Copyright (c) 2017 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier Espana, S.L.U. All rights reserved. FAU - Rio, Pedro AU - Rio P AD - Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal. Electronic address: pedrosantosrio@gmail.com. FAU - Oliveira, Mario Martins AU - Oliveira MM AD - Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal. FAU - Cunha, Pedro Silva AU - Cunha PS AD - Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal. FAU - da Silva, Manuel Nogueira AU - da Silva MN AD - Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal. FAU - Branco, Luisa Moura AU - Branco LM AD - Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal. FAU - Galrinho, Ana AU - Galrinho A AD - Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal. FAU - Soares, Rui AU - Soares R AD - Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal. FAU - Feliciano, Joana AU - Feliciano J AD - Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal. FAU - Pimenta, Ricardo AU - Pimenta R AD - Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal. FAU - Ferreira, Rui Cruz AU - Ferreira RC AD - Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisbon, Portugal. LA - eng LA - por PT - Journal Article DEP - 20171208 PL - Portugal TA - Rev Port Cardiol JT - Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology JID - 8710716 SB - IM CIN - Rev Port Cardiol. 2017 Dec;36(12 ):893-894. PMID: 29233645 MH - *Cardiac Resynchronization Therapy MH - *Defibrillators, Implantable MH - Female MH - Heart Failure/*therapy MH - Humans MH - Male MH - Middle Aged MH - Retrospective Studies MH - Time Factors MH - Treatment Failure OTO - NOTNLM OT - Cardiac resynchronization therapy OT - Clinical response OT - Heart failure OT - Insuficiencia cardiaca OT - Prognosis OT - Prognostico OT - Resposta clinica OT - Terapia de ressincronizacao cardiaca EDAT- 2017/12/12 06:00 MHDA- 2019/01/03 06:00 CRDT- 2017/12/12 06:00 PHST- 2016/11/26 00:00 [received] PHST- 2017/02/14 00:00 [revised] PHST- 2017/02/23 00:00 [accepted] PHST- 2017/12/12 06:00 [pubmed] PHST- 2019/01/03 06:00 [medline] PHST- 2017/12/12 06:00 [entrez] AID - S0870-2551(16)30370-5 [pii] AID - 10.1016/j.repc.2017.02.017 [doi] PST - ppublish SO - Rev Port Cardiol. 2017 Dec;36(12):885-892. doi: 10.1016/j.repc.2017.02.017. Epub 2017 Dec 8.